Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
IINN 
Inspira Technologies Oxy BHN Ltd (IINN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: IINN (3-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $5
1 Year Target Price $5
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 87% | Avg. Invested days 32 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  4.0 |
| Profits based on simulation | Last Close 09/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 37.29M USD | Price to earnings Ratio - | 1Y Target Price 5 |
Price to earnings Ratio - | 1Y Target Price 5 | ||
Volume (30-day avg) 1 | Beta 2.29 | 52 Weeks Range 0.40 - 1.65 | Updated Date 09/14/2025 |
52 Weeks Range 0.40 - 1.65 | Updated Date 09/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.6 |
Earnings Date
Report Date 2025-08-29 | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -81.03% | Return on Equity (TTM) -219.74% |
Valuation
Trailing PE - | Forward PE 11 | Enterprise Value 32161839 | Price to Sales(TTM) - |
Enterprise Value 32161839 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA -0.15 | Shares Outstanding 30814700 | Shares Floating 24090830 |
Shares Outstanding 30814700 | Shares Floating 24090830 | ||
Percent Insiders 8.75 | Percent Institutions 4.39 |
Upturn AI SWOT
Inspira Technologies Oxy BHN Ltd
Company Overview
History and Background
Inspira Technologies Oxy BHN Ltd is an Israeli medical technology company. Founded in 2018, it focuses on developing breakthrough respiratory support technology. The company went public via an IPO, aiming to disrupt the acute respiratory care market.
Core Business Areas
- Respiratory Support Systems: Development and commercialization of respiratory support devices designed to prevent the need for invasive mechanical ventilation.
Leadership and Structure
The company is led by a management team focused on medical device development and commercialization. The organizational structure includes research and development, regulatory affairs, and business development departments.
Top Products and Market Share
Key Offerings
- ARTRA System: The ARTRA system aims to prevent the need for mechanical ventilation by directly oxygenating blood extracorporeally. It's designed for early intervention in respiratory failure. There are currently no revenue or market share available since this is still in the pipeline. Competitors include firms offering traditional mechanical ventilators (e.g., Medtronic, Getinge, Dru00e4ger).
Market Dynamics
Industry Overview
The respiratory care market is driven by aging populations, increasing prevalence of respiratory diseases, and technological advancements. The market is characterized by intense competition and regulatory scrutiny.
Positioning
Inspira Technologies aims to disrupt the market with its ARTRA system, offering a less invasive alternative to traditional mechanical ventilation. The company positions itself as an innovator in respiratory care.
Total Addressable Market (TAM)
The TAM for respiratory support devices is estimated at several billion USD annually. Inspira Technologies aims to capture a portion of this market by providing an early intervention solution. Due to the product being in the pipeline, it is difficult to predict market share at this stage.
Upturn SWOT Analysis
Strengths
- Innovative technology
- Potential to reduce reliance on mechanical ventilation
- Experienced management team
Weaknesses
- Limited commercialization experience
- Dependence on regulatory approvals
- Relatively small size compared to competitors
Opportunities
- Expanding respiratory care market
- Partnerships with hospitals and healthcare providers
- Potential for international expansion
Threats
- Competition from established players
- Regulatory hurdles
- Technological advancements by competitors
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- Getinge (GETI-B.ST)
- Dru00e4gerwerk (DRW.DE)
Competitive Landscape
Inspira Technologies offers a new approach to respiratory support, but it faces strong competition from larger, established companies.
Growth Trajectory and Initiatives
Historical Growth: Growth will be evaluated based on regulatory approvals and subsequent commercialization.
Future Projections: Future growth is dependent on product acceptance and market penetration.
Recent Initiatives: Recent strategic initiatives include securing regulatory approvals and expanding collaborations.
Summary
Inspira Technologies is an early-stage medical device company with an innovative technology aimed at preventing mechanical ventilation. The company is facing significant competition from established players and relies on successful regulatory approval for its product to enter the market. Inspira's ability to secure regulatory clearances and establish market presence is crucial for its future success. The success will be dependent on cash flow management and product acceptance.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- Press releases
- Analyst reports
- SEC filings
Disclaimers:
This analysis is based on available public information and analyst estimates. It is not financial advice, and readers should conduct their own research before making investment decisions. Market share numbers are estimates and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Inspira Technologies Oxy BHN Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-07-14 | Co-Founder, CEO & Director Mr. Dagi Shahar Ben-Noon | ||
Sector Healthcare | Industry Medical Devices | Full time employees 37 | Website https://inspira-technologies.com |
Full time employees 37 | Website https://inspira-technologies.com | ||
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.